Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
We explain how crypto assets resemble tokens and coins, highlighting differences in functionality, value, and governance.
28,655 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A coalition of silicon valley insiders warns that the United States is underprepared for modern warfare, with wide-re...
Oil and gas markets await a week of concrete moves after Trump pledged ‘free flow’ of energy from the Middle East. An...
A couple in their mid-60s weighs the cost of restoring classic cars against steady portfolio income as market conditi...
Elon Musk publicly backs Warren Buffett’s long-running deficit-cap idea, positioning the plan as a potential pivot in...
SpaceX's blockbuster IPO delivered record cash and a sky-high valuation, but a $17 billion mispricing—the billion mis...
Global defense budgets are expanding, driving gains in aerospace and defense equities. The ITA ETF offers access to a...
The White House says the trip will be brief, while diplomats work toward a framework on Iran's nuclear program and re...
A Reuters briefing this week reignited the debate over Banksy’s anonymity and its effect on art values, prompting a r...
As AI use grows across major tech firms, worker morale and collaboration are under strain. A close look at Anthropic’...
Delek Logistics Partners has logged 13 years of rising payouts, but 2025 cash flow barely covers distributions, promp...
U.S. stock futures rose Monday as traders brace for a holiday-shortened week, with fresh analyst calls across Adobe, ...